Retatrutide is a triple agonist that activates three receptors: GLP-1, GIP, and glucagon
Not for human or animal consumption, medical treatment, or diagnostic use
Standard shipping should take 3-5 days
Important safety considerations include risk of pancreatitis (treatment should be discontinued if suspected), gallbladder disease, and potential worsening of diabetic retinopathy in patients with pre-existing retinopathy who experience rapid improvement in glucose control (particularly with semaglutide)
Be sure to tell your doctor and pharmacist about everything you take, including prescription and over-the-counter medications, vitamins, herbs, other supplements, or other drugs
BPC-157 switches on blood-vessel-growth signals and calms inflammation at the site of injury